Unigestion Holding Sa Bio Techne Corp Transaction History

Unigestion Holding Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$353.85 - $487.79 $136,939 - $188,774	-387 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $839,772 - $966,635	-1,841 Reduced 82.63%	387 $200,000
Q3 2021 Oct 14, 2021	BUY	$444.87 - $538.88 $136,575 - $165,436	307 Added 15.98%	2,228 $1.09 Million
Q2 2021 Jul 29, 2021	SELL	$387.35 - $450.26 $227,374 - $264,302	-587 Reduced 23.41%	1,921 $860,000
Q1 2021 May 05, 2021	SELL	$314.62 - $411.0 $155,107 - $202,623	-493 Reduced 16.43%	2,508 $958,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $162,707 - $212,112	659 Added 28.14%	3,001 $953,000
Q3 2020 Nov 10, 2020	BUY	$232.22 - $282.96 $543,859 - $662,692	2,342 New	2,342 $580,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Unigestion Holding Sa with notifications on news.